Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: A biocompatible, size-tunable contrast agent for magnetic resonance imaging

Harald Unterweger, Christina Janko, Marc Schwarz, László Dézsi, Rudolf Urbanics, Jasmin Matuszak, Erik Őrfi, Tamás Fülöp, Tobias Bäuerle, J. Szebeni, Clément Journé, Aldo R. Boccaccini, Christoph Alexiou, Stefan Lyer, Iwona Cicha

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Iron oxide-based contrast agents have been in clinical use for magnetic resonance imaging (MRI) of lymph nodes, liver, intestines, and the cardiovascular system. Superparamagnetic iron oxide nanoparticles (SPIONs) have high potential as a contrast agent for MRI, but no intravenous iron oxide-containing agents are currently approved for clinical imaging. The aim of our work was to analyze the hemocompatibility and immuno-safety of a new type of dextran-coated SPIONs (SPIONdex) and to characterize these nanoparticles with ultra-high-field MRI. Key parameters related to nanoparticle hemocompatibility and immuno-safety were investigated in vitro and ex vivo. To address concerns associated with hypersensitivity reactions to injectable nanoparticulate agents, we analyzed complement activation-related pseudoallergy (CARPA) upon intravenous administration of SPIONdex in a pig model. Furthermore, the size-tunability of SPIONdex and the effects of size reduction on their biocompatibility were investigated. In vitro, SPIONdex did not induce hemolysis, complement or platelet activation, plasma coagulation, or leukocyte procoagulant activity, and had no relevant effect on endothelial cell viability or endothelial–monocytic cell interactions. Furthermore, SPIONdex did not induce CARPA even upon intravenous administration of 5 mg Fe/kg in pigs. Upon SPIONdex administration in mice, decreased liver signal intensity was observed after 15 minutes and was still detectable 24 h later. In addition, by changing synthesis parameters, a reduction in particle size <30 nm was achieved, without affecting their hemo- and biocompatibility. Our findings suggest that due to their excellent biocompatibility, safety upon intravenous administration and size-tunability, SPIONdex particles may represent a suitable candidate for a new-generation MRI contrast agent.

Original languageEnglish
Pages (from-to)5223-5238
Number of pages16
JournalInternational Journal of Nanomedicine
Volume12
DOIs
Publication statusPublished - Jul 24 2017

Fingerprint

Dextran
Magnetic resonance
Iron oxides
Nanoparticles
Contrast Media
Complement Activation
Biocompatibility
Magnetic Resonance Imaging
Intravenous Administration
Imaging techniques
Chemical activation
Safety
Liver
Swine
Cardiovascular system
Endothelial cells
Platelet Activation
Medical imaging
Cardiovascular System
Platelets

Keywords

  • Hemocompatibility
  • Hypersensitivity reaction
  • MRI
  • SPION uptake
  • Superparamagnetic iron oxide nanoparticles

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Drug Discovery
  • Organic Chemistry

Cite this

Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles : A biocompatible, size-tunable contrast agent for magnetic resonance imaging. / Unterweger, Harald; Janko, Christina; Schwarz, Marc; Dézsi, László; Urbanics, Rudolf; Matuszak, Jasmin; Őrfi, Erik; Fülöp, Tamás; Bäuerle, Tobias; Szebeni, J.; Journé, Clément; Boccaccini, Aldo R.; Alexiou, Christoph; Lyer, Stefan; Cicha, Iwona.

In: International Journal of Nanomedicine, Vol. 12, 24.07.2017, p. 5223-5238.

Research output: Contribution to journalArticle

Unterweger, H, Janko, C, Schwarz, M, Dézsi, L, Urbanics, R, Matuszak, J, Őrfi, E, Fülöp, T, Bäuerle, T, Szebeni, J, Journé, C, Boccaccini, AR, Alexiou, C, Lyer, S & Cicha, I 2017, 'Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: A biocompatible, size-tunable contrast agent for magnetic resonance imaging', International Journal of Nanomedicine, vol. 12, pp. 5223-5238. https://doi.org/10.2147/IJN.S138108
Unterweger, Harald ; Janko, Christina ; Schwarz, Marc ; Dézsi, László ; Urbanics, Rudolf ; Matuszak, Jasmin ; Őrfi, Erik ; Fülöp, Tamás ; Bäuerle, Tobias ; Szebeni, J. ; Journé, Clément ; Boccaccini, Aldo R. ; Alexiou, Christoph ; Lyer, Stefan ; Cicha, Iwona. / Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles : A biocompatible, size-tunable contrast agent for magnetic resonance imaging. In: International Journal of Nanomedicine. 2017 ; Vol. 12. pp. 5223-5238.
@article{ee5478a612864fa5a8ad1222327d00ec,
title = "Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: A biocompatible, size-tunable contrast agent for magnetic resonance imaging",
abstract = "Iron oxide-based contrast agents have been in clinical use for magnetic resonance imaging (MRI) of lymph nodes, liver, intestines, and the cardiovascular system. Superparamagnetic iron oxide nanoparticles (SPIONs) have high potential as a contrast agent for MRI, but no intravenous iron oxide-containing agents are currently approved for clinical imaging. The aim of our work was to analyze the hemocompatibility and immuno-safety of a new type of dextran-coated SPIONs (SPIONdex) and to characterize these nanoparticles with ultra-high-field MRI. Key parameters related to nanoparticle hemocompatibility and immuno-safety were investigated in vitro and ex vivo. To address concerns associated with hypersensitivity reactions to injectable nanoparticulate agents, we analyzed complement activation-related pseudoallergy (CARPA) upon intravenous administration of SPIONdex in a pig model. Furthermore, the size-tunability of SPIONdex and the effects of size reduction on their biocompatibility were investigated. In vitro, SPIONdex did not induce hemolysis, complement or platelet activation, plasma coagulation, or leukocyte procoagulant activity, and had no relevant effect on endothelial cell viability or endothelial–monocytic cell interactions. Furthermore, SPIONdex did not induce CARPA even upon intravenous administration of 5 mg Fe/kg in pigs. Upon SPIONdex administration in mice, decreased liver signal intensity was observed after 15 minutes and was still detectable 24 h later. In addition, by changing synthesis parameters, a reduction in particle size <30 nm was achieved, without affecting their hemo- and biocompatibility. Our findings suggest that due to their excellent biocompatibility, safety upon intravenous administration and size-tunability, SPIONdex particles may represent a suitable candidate for a new-generation MRI contrast agent.",
keywords = "Hemocompatibility, Hypersensitivity reaction, MRI, SPION uptake, Superparamagnetic iron oxide nanoparticles",
author = "Harald Unterweger and Christina Janko and Marc Schwarz and L{\'a}szl{\'o} D{\'e}zsi and Rudolf Urbanics and Jasmin Matuszak and Erik Őrfi and Tam{\'a}s F{\"u}l{\"o}p and Tobias B{\"a}uerle and J. Szebeni and Cl{\'e}ment Journ{\'e} and Boccaccini, {Aldo R.} and Christoph Alexiou and Stefan Lyer and Iwona Cicha",
year = "2017",
month = "7",
day = "24",
doi = "10.2147/IJN.S138108",
language = "English",
volume = "12",
pages = "5223--5238",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles

T2 - A biocompatible, size-tunable contrast agent for magnetic resonance imaging

AU - Unterweger, Harald

AU - Janko, Christina

AU - Schwarz, Marc

AU - Dézsi, László

AU - Urbanics, Rudolf

AU - Matuszak, Jasmin

AU - Őrfi, Erik

AU - Fülöp, Tamás

AU - Bäuerle, Tobias

AU - Szebeni, J.

AU - Journé, Clément

AU - Boccaccini, Aldo R.

AU - Alexiou, Christoph

AU - Lyer, Stefan

AU - Cicha, Iwona

PY - 2017/7/24

Y1 - 2017/7/24

N2 - Iron oxide-based contrast agents have been in clinical use for magnetic resonance imaging (MRI) of lymph nodes, liver, intestines, and the cardiovascular system. Superparamagnetic iron oxide nanoparticles (SPIONs) have high potential as a contrast agent for MRI, but no intravenous iron oxide-containing agents are currently approved for clinical imaging. The aim of our work was to analyze the hemocompatibility and immuno-safety of a new type of dextran-coated SPIONs (SPIONdex) and to characterize these nanoparticles with ultra-high-field MRI. Key parameters related to nanoparticle hemocompatibility and immuno-safety were investigated in vitro and ex vivo. To address concerns associated with hypersensitivity reactions to injectable nanoparticulate agents, we analyzed complement activation-related pseudoallergy (CARPA) upon intravenous administration of SPIONdex in a pig model. Furthermore, the size-tunability of SPIONdex and the effects of size reduction on their biocompatibility were investigated. In vitro, SPIONdex did not induce hemolysis, complement or platelet activation, plasma coagulation, or leukocyte procoagulant activity, and had no relevant effect on endothelial cell viability or endothelial–monocytic cell interactions. Furthermore, SPIONdex did not induce CARPA even upon intravenous administration of 5 mg Fe/kg in pigs. Upon SPIONdex administration in mice, decreased liver signal intensity was observed after 15 minutes and was still detectable 24 h later. In addition, by changing synthesis parameters, a reduction in particle size <30 nm was achieved, without affecting their hemo- and biocompatibility. Our findings suggest that due to their excellent biocompatibility, safety upon intravenous administration and size-tunability, SPIONdex particles may represent a suitable candidate for a new-generation MRI contrast agent.

AB - Iron oxide-based contrast agents have been in clinical use for magnetic resonance imaging (MRI) of lymph nodes, liver, intestines, and the cardiovascular system. Superparamagnetic iron oxide nanoparticles (SPIONs) have high potential as a contrast agent for MRI, but no intravenous iron oxide-containing agents are currently approved for clinical imaging. The aim of our work was to analyze the hemocompatibility and immuno-safety of a new type of dextran-coated SPIONs (SPIONdex) and to characterize these nanoparticles with ultra-high-field MRI. Key parameters related to nanoparticle hemocompatibility and immuno-safety were investigated in vitro and ex vivo. To address concerns associated with hypersensitivity reactions to injectable nanoparticulate agents, we analyzed complement activation-related pseudoallergy (CARPA) upon intravenous administration of SPIONdex in a pig model. Furthermore, the size-tunability of SPIONdex and the effects of size reduction on their biocompatibility were investigated. In vitro, SPIONdex did not induce hemolysis, complement or platelet activation, plasma coagulation, or leukocyte procoagulant activity, and had no relevant effect on endothelial cell viability or endothelial–monocytic cell interactions. Furthermore, SPIONdex did not induce CARPA even upon intravenous administration of 5 mg Fe/kg in pigs. Upon SPIONdex administration in mice, decreased liver signal intensity was observed after 15 minutes and was still detectable 24 h later. In addition, by changing synthesis parameters, a reduction in particle size <30 nm was achieved, without affecting their hemo- and biocompatibility. Our findings suggest that due to their excellent biocompatibility, safety upon intravenous administration and size-tunability, SPIONdex particles may represent a suitable candidate for a new-generation MRI contrast agent.

KW - Hemocompatibility

KW - Hypersensitivity reaction

KW - MRI

KW - SPION uptake

KW - Superparamagnetic iron oxide nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85026481289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026481289&partnerID=8YFLogxK

U2 - 10.2147/IJN.S138108

DO - 10.2147/IJN.S138108

M3 - Article

C2 - 28769560

AN - SCOPUS:85026481289

VL - 12

SP - 5223

EP - 5238

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -